Last edition
News about
Alkem Launches Pertuzumab Biosimilar Pertuza in India for HER2-Positive Breast Cancer
Alkem Laboratories has introduced Pertuza, a biosimilar of pertuzumab, in India for the treatment of HER2-positive breast cancer. The drug is supplied as a 420 mg/14 mL injection and is developed and manufactured domestically.
Palatin Technologies, the US-based biopharmaceutical company focused on developing medicines that modulate the melanocortin receptor system, announced it has achieved a research milestone under its collaboration with Boehringer Ingelheim, triggering a 6.5 million payment to the company.
The first participant has been dosed in the pivotal Phase III exPDite-2 trial of bemdaneprocel, an investigational cell therapy, while the first European participants have been enrolled in REGENERATE-PD, a Phase II trial of the gene therapy AB-1005.
Agilent Technologies, Lunit Partner to Develop AI-Powered Companion Diagnostic Tools
Agilent Technologies has entered into a nonexclusive collaboration with Korea-based Lunit to develop AI-based companion diagnostic solutions.
Pfizer to Acquire Metsera, Expand Obesity and Cardiometabolic Drug Pipeline
Pfizer is set to acquire Metsera, a clinical-stage biopharmaceutical company focused on developing the next generation of medicines for obesity and cardiometabolic diseases.
USFDA Completes Inspection of Indoco API Plant in Patalganga with Zero Observations
The inspection of Indoco’s API manufacturing facility at Patalganga by the US FDA concluded with zero form 483 observations.
Cold Chain Technologies Powers Smarter Specialty Pharmacies
Cold Chain Technologies is reshaping cold chain logistics for specialty pharmacies with its digital tools — CCT Route Pro and Lane Risk. Route Pro ensures confident, season-proof shipping, while Lane Risk alerts teams to severe weather, helping prevent delays and excursions.
Pharma Pro & Pack Expo 2025: CN Water Unveils AQU@Sense and Remote Monitoring Platform
India’s leading high-purity water solutions company, CN Water, concluded a successful showcase at the Pharma Pro & Pack Expo 2025 in India, highlighting two of its industry-leading solutions - AQU@Sense and CNtinel Remote Monitoring platform - which are redefining water operations for pharmaceutical manufacturing.
Rubicon Research, a pharmaceutical formulations company, has announced that in a pre-IPO transaction, General Atlantic Singapore RR transferred 2.889 million equity shares to TIMF Holdings and 360 ONE funds at INR 484.47 per share, aggregating to INR 140 crore.
Akums Highlights Lacosamide's Versatility in Epilepsy Management
Akums Drugs & Pharmaceuticals reaffirmed lacosamide, a well-established antiepileptic drug (AED), as a versatile and effective option for patients with epilepsy across age groups and clinical settings.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy